Literature DB >> 28078710

Cancer Stem Cells (CSCs) in melanoma: There's smoke, but is there fire?

Constance E Brinckerhoff1.   

Abstract

Cancer stem cells (CSCs), also called Tumor Initiating Cells (TICs), can be defined as cancer cells that are present within solid tumors or hematological cancers, which have characteristics associated with normal stem cells, but which can give rise to all cell types found in a particular cancer sample. CSCs, therefore, are transformed stem cells, which can self-renew, differentiate into diverse progenies, and drive continuous tumor growth (Kreso & Dick, , Cell Stem Cell, 14:275-291; Schatton et al., , Nature, 451:345-349; Villani, Sabbatino, Ferrone, & Ferrone, , Melanoma Management, 2:109-114; Zhou et al., , Drug Discovery, 8:806-823) (Fig. ). [Figure: see text].
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  humanized mice; innate and adaptive immunity; phenotypic plasticity; tumor initiating cells

Mesh:

Substances:

Year:  2017        PMID: 28078710      PMCID: PMC5482763          DOI: 10.1002/jcp.25796

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  27 in total

1.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

Review 2.  Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations.

Authors:  Kiera Rycaj; Dean G Tang
Journal:  Cancer Res       Date:  2015-08-19       Impact factor: 12.701

Review 3.  Evolution of the cancer stem cell model.

Authors:  Antonija Kreso; John E Dick
Journal:  Cell Stem Cell       Date:  2014-03-06       Impact factor: 24.633

Review 4.  Humanized hemato-lymphoid system mice.

Authors:  Alexandre P A Theocharides; Anthony Rongvaux; Kristin Fritsch; Richard A Flavell; Markus G Manz
Journal:  Haematologica       Date:  2016-01       Impact factor: 9.941

5.  Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells.

Authors:  Michela Perego; Monica Tortoreto; Gabrina Tragni; Luigi Mariani; Paola Deho; Antonino Carbone; Mario Santinami; Roberto Patuzzo; Pamela Della Mina; Antonello Villa; Graziella Pratesi; Giacomo Cossa; Paola Perego; Maria G Daidone; Malcolm R Alison; Giorgio Parmiani; Licia Rivoltini; Chiara Castelli
Journal:  J Invest Dermatol       Date:  2010-04-08       Impact factor: 8.551

6.  Identification of cells initiating human melanomas.

Authors:  Tobias Schatton; George F Murphy; Natasha Y Frank; Kazuhiro Yamaura; Ana Maria Waaga-Gasser; Martin Gasser; Qian Zhan; Stefan Jordan; Lyn M Duncan; Carsten Weishaupt; Robert C Fuhlbrigge; Thomas S Kupper; Mohamed H Sayegh; Markus H Frank
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

7.  Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.

Authors:  Gabriella Pietra; Claudia Manzini; Massimo Vitale; Mirna Balsamo; Emanuela Ognio; Monica Boitano; Paola Queirolo; Lorenzo Moretta; Maria Cristina Mingari
Journal:  Int Immunol       Date:  2009-06-02       Impact factor: 4.823

8.  Human melanoma metastasis in NSG mice correlates with clinical outcome in patients.

Authors:  Elsa Quintana; Elena Piskounova; Mark Shackleton; Daniel Weinberg; Ugur Eskiocak; Douglas R Fullen; Timothy M Johnson; Sean J Morrison
Journal:  Sci Transl Med       Date:  2012-11-07       Impact factor: 17.956

9.  Cancer immunoediting by the innate immune system in the absence of adaptive immunity.

Authors:  Timothy O'Sullivan; Robert Saddawi-Konefka; William Vermi; Catherine M Koebel; Cora Arthur; J Michael White; Ravi Uppaluri; Daniel M Andrews; Shin Foong Ngiow; Michele W L Teng; Mark J Smyth; Robert D Schreiber; Jack D Bui
Journal:  J Exp Med       Date:  2012-08-27       Impact factor: 14.307

10.  CD271 is an imperfect marker for melanoma initiating cells.

Authors:  Yann Cheli; Vanessa F Bonnazi; Arnaud Jacquel; Maryline Allegra; Gian Marco De Donatis; Philippe Bahadoran; Corine Bertolotto; Robert Ballotti
Journal:  Oncotarget       Date:  2014-07-30
View more
  13 in total

Review 1.  Cell-state dynamics and therapeutic resistance in melanoma from the perspective of MITF and IFNγ pathways.

Authors:  Xue Bai; David E Fisher; Keith T Flaherty
Journal:  Nat Rev Clin Oncol       Date:  2019-09       Impact factor: 66.675

2.  Clinicopathological characteristics of malignant melanomas of the skin and gastrointestinal tract.

Authors:  Michiko Akiyama; Yoko Matsuda; Tomio Arai; Hidehisa Saeki
Journal:  Oncol Lett       Date:  2018-06-06       Impact factor: 2.967

Review 3.  Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.

Authors:  Simin Zhang; Zhen Yang; Fazhi Qi
Journal:  Mol Biol Rep       Date:  2019-12-14       Impact factor: 2.316

4.  Expression of vimentin and Oct-4 in gallbladder adenocarcinoma and their relationship with vasculogenic mimicry and their clinical significance.

Authors:  Yu Zhang; Jing Xu; Zhouyi Xu; Yichao Wang; Shiwu Wu; Lu Wu; Hong Song; Lei Zhou
Journal:  Int J Clin Exp Pathol       Date:  2018-07-01

Review 5.  Phenotype plasticity as enabler of melanoma progression and therapy resistance.

Authors:  Imanol Arozarena; Claudia Wellbrock
Journal:  Nat Rev Cancer       Date:  2019-06-17       Impact factor: 60.716

6.  In Vivo Study on the Effects of Xiaoaiping on the Stemness of Hepatocellular Carcinoma Cells.

Authors:  Jing Zhan; Liang-Liang Shi; Yan Wang; Bai Wei; Sheng-Li Yang
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-23       Impact factor: 2.629

Review 7.  Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.

Authors:  Xixi Dou; Pingzhen Tong; Hai Huang; Lucas Zellmer; Yan He; Qingwen Jia; Daizhou Zhang; Jiang Peng; Chenguang Wang; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

8.  Targeting melanoma stem cells with the Vitamin E derivative δ-tocotrienol.

Authors:  Monica Marzagalli; Roberta Manuela Moretti; Elio Messi; Marina Montagnani Marelli; Fabrizio Fontana; Alessia Anastasia; Maria Rosa Bani; Giangiacomo Beretta; Patrizia Limonta
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

Review 9.  Intratumor and Intertumor Heterogeneity in Melanoma.

Authors:  Tomasz M Grzywa; Wiktor Paskal; Paweł K Włodarski
Journal:  Transl Oncol       Date:  2017-10-24       Impact factor: 4.243

Review 10.  Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma.

Authors:  Lucia Demkova; Lucia Kucerova
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.